Mouse study indicates that triptans could be used to treat obesity

21 Jul 2022

New research published in the Journal of Experimental Medicine suggests that common migraine drugs can promote weight loss, the murine study reported that frovatriptan was the most effective in supressing hunger.

Medical News Today

Related Topics

Metabolism Obesity Endocrine-Disrupting Chemicals

Share this story